These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Long-term treatment of SOD1 ALS with tofersen: a multicentre experience in 17 patients. Sabatelli M; Cerri F; Zuccarino R; Patanella AK; Bernardo D; Bisogni G; Tanel R; Sansone V; Filosto M; Lattante S; Martello F; Doronzio PN; Stano S; Zanfini BA; Coccia M; Costantini EM; Lizio A; Lucioli G; Padovani A; Merlini GP; Conte A J Neurol; 2024 Aug; 271(8):5177-5186. PubMed ID: 38829431 [TBL] [Abstract][Full Text] [Related]
13. Breaking barriers with tofersen: Enhancing therapeutic opportunities in amyotrophic lateral sclerosis. Saini A; Chawla PA Eur J Neurol; 2024 Feb; 31(2):e16140. PubMed ID: 37975798 [TBL] [Abstract][Full Text] [Related]
14. Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients. Weishaupt JH; Körtvélyessy P; Schumann P; Valkadinov I; Weyen U; Hesebeck-Brinckmann J; Weishaupt K; Endres M; Andersen PM; Regensburger M; Dreger M; Koch JC; Conrad J; Meyer T Commun Med (Lond); 2024 Jul; 4(1):150. PubMed ID: 39054363 [TBL] [Abstract][Full Text] [Related]
15. Analysis of SOD1 variants in Chinese patients with familial amyotrophic lateral sclerosis. Li H; Yuan L; Yang H; Guo Y; Zheng W; Fan K; Deng S; Gong L; Xu H; Yang Z; Cheng J; Kang M; Deng H QJM; 2023 May; 116(5):365-374. PubMed ID: 36661322 [TBL] [Abstract][Full Text] [Related]
16. Myelitis as a side effect of tofersen therapy in SOD1-associated ALS. Reilich P; Schöberl F; Hiebeler M; Tonon M; Ludolph AC; Senel M J Neurol; 2024 Apr; 271(4):2114-2118. PubMed ID: 38066205 [No Abstract] [Full Text] [Related]
17. Antisense Oligonucleotides for the Study and Treatment of ALS. Boros BD; Schoch KM; Kreple CJ; Miller TM Neurotherapeutics; 2022 Jul; 19(4):1145-1158. PubMed ID: 35653060 [TBL] [Abstract][Full Text] [Related]
19. Inclusions in macrophages of the cerebrospinal fluid during treatment with Tofersen. Sparasci D; Castelli C; Staedler C; Gobbi C; Ripellino P Muscle Nerve; 2023 Feb; 67(2):E3-E5. PubMed ID: 36477882 [No Abstract] [Full Text] [Related]
20. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]